Previous NUCATS CTSA TL1 Fellows

  • Brian T. Burmeister, PhD

    Mentor: Paul W Burridge, PhD
    Determining the Mechanism of Pediatric Doxorubicin-Induced Cardiotoxicity
    Dr. Burmeister will be studying patient-specific responses to chemotherapy agents, specifically doxorubicin which is used to treat pediatric cancer patients. Doxorubicin is very effective in treating pediatric cancer, however one of the drug’s side effects, cardiotoxicity, limits it’s usefulness. As a result, Dr. Burmeister will be working to determine the molecular mechanisms that regulate doxorubicin-induced cardiotoxicity in order to identify new targets for drug discovery.
  • Daniel Giles Fort, MPH PhD

    Mentor: Justin B Starren, MD/PhD
    Susanna A McColley, MD
    Informatics Interventions to Accelerate Pediatric Clinical Trial Recruitment
    Dan Fort, PhD, MPH, will be researching ways to use informatics in order to accelerate pediatric clinical trial recruitment. To do this, he will be looking at patterns in clinical trial recruitment success and failure as well as digging into historical cohort selection queries for insights into how they might be modified to increase the number of patients identified for recruitment. “This award is vital early career support, allowing me to build a solid body of investigatory, preliminary work for R-scale funding proposals as well as address important skill gaps in team and decision sciences,” said Dr. Fort.